Evidence map›Paper›PMID 40636900›Full record

ArticleFrontiers in aging neuroscience2025

Modeling heterogeneity in cognitive trajectories in the Framingham Heart Study.

Yuan Fang, Jiachen Chen, Jesse Mez, Claudia L Satizabal, Michael L Alosco, Wei Qiao Qiu, Margaret F Doyle, Joanne M Murabito, Kathryn L Lunetta

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The importance of modifiable lifestyle factors for episodic memory: a gradient boosted tree analysis.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuan FangDepartment of Pharmaceutical Sciences, Binghamton University School of Pharmacy and Pharmaceutical Sciences, State University of New York, Binghamton, NY, United States.
Jiachen ChenDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, United States.
Jesse MezBoston University Alzheimer's Disease Research Center and CTE Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Claudia L SatizabalDepartment of Neurology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Michael L AloscoBoston University Alzheimer's Disease Research Center and CTE Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Wei Qiao QiuBoston University Alzheimer's Disease Research Center and CTE Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Margaret F DoyleDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, United States.
Joanne M MurabitoFramingham Heart Study, National Heart, Lung, and Blood Institute and Boston University Chobanian and Avedisian School of Medicine, Framingham, MA, United States.
Kathryn L LunettaDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, United States.

Funding

Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)R01AG061028 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN, MEZ, JESSE BENJAMIN · 2019 to 2023
$5.9M
Role of Peripheral Immune Cells in Cognitive Aging: The Framingham Offspring StudyR01AG067457 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DOYLE, MARGARET F., LUNETTA, KATHRYN L · 2020 to 2024
$3.4M
NIA NIH HHS R01 AG061028NIA NIH HHS R01 AG067457
6 · The paper itself

Abstract

Introduction: The prevalence of cognitive impairment in the population is growing; however, there is substantial heterogeneity in the rate of decline across different cognitive domains. Harmonized factor scores measuring memory, executive function, and language domains have been created in the Framingham Heart Study (FHS). Methods: This work identified FHS participants with two or more repeated factor scores after age 60 and fitted latent class mixed models (LCMM) to cluster cognitive trajectories within each domain. Non-linear shapes of trajectories were modeled piecewise linearly, followed by stepwise selections to select cluster-specific change points. Results: We identified different latent classes of participants with early cognitive decline, compared to late decliners, for each domain. Ten-fold cross-validation yielded stable subgroupings. Our findings show latent-class-related differential patterns in cognitive aging in the FHS. We also investigated the association between identified latent classes with existing protein biomarkers of cognitive aging in a subsample of the study and found elevated levels of CD40L and CD14 were associated with a higher risk of early decline in memory and executive function domain, respectively. Discussion: In summary, our study advances the understanding of cognitive decline heterogeneity among FHS participants and sets the stage for further investigations into early intervention strategies and personalized approaches to mitigate cognitive aging risks.

Indexed as

clusteringcognitive declinecognitive trajectoriesFramingham Heart Study (FHS)latent class mixed models (LCMM)

Identifiers

PMID40636900
PMCPMC12238755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.